Custom Antibody Market Projected to Reach $901 Million by 2029, Growing at 9.2% CAGR
Custom Antibody Market Projected to Reach $901 Million by 2029, Growing at 9.2% CAGR

According to a new report by MarketsandMarkets™, the global Custom Antibody Market is expected to experience significant growth over the next five years. The market, estimated to be worth $579 million in 2024, is projected to reach $901 million by 2029, exhibiting a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period.

Download an Illustrative overview:

The rise in demand for custom antibodies is attributed to advancements in therapeutic antibody development, increased investment in research and development in the biotechnology and pharmaceutical sectors, and the growing focus on personalized medicine. Custom antibodies, designed to target specific antigens, play a critical role in diagnostics, therapeutic applications, and drug discovery.

Key drivers of growth include:

·         Increased use of custom antibodies in cancer research and immunotherapy.

·         Rising demand for advanced diagnostic and therapeutic tools in the healthcare sector.

Request Sample Pages:

Growing focus on precision medicine and targeted therapies.

The report highlights that North America holds the largest market share, with substantial growth opportunities in the Asia-Pacific region, driven by expanding research initiatives and advancements in biopharmaceutical industries.

Content Source:

https://www.marketsandmarkets.com/PressReleases/custom-antibody.asp

https://www.marketsandmarkets.com/ResearchInsight/custom-antibody-market.asp

https://www.prnewswire.com/news-releases/custom-antibody-market-worth-901-million--marketsandmarkets-302164520.html

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Custom Antibody Market Projected to Reach $901 Million by 2029, Growing at 9.2% CAGR
disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/public/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations